Correlation Between Neuroone Medical and Bluejay Diagnostics
Can any of the company-specific risk be diversified away by investing in both Neuroone Medical and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuroone Medical and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuroone Medical Technologies and Bluejay Diagnostics, you can compare the effects of market volatilities on Neuroone Medical and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuroone Medical with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuroone Medical and Bluejay Diagnostics.
Diversification Opportunities for Neuroone Medical and Bluejay Diagnostics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neuroone and Bluejay is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Neuroone Medical Technologies and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and Neuroone Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuroone Medical Technologies are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of Neuroone Medical i.e., Neuroone Medical and Bluejay Diagnostics go up and down completely randomly.
Pair Corralation between Neuroone Medical and Bluejay Diagnostics
Given the investment horizon of 90 days Neuroone Medical Technologies is expected to under-perform the Bluejay Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Neuroone Medical Technologies is 4.82 times less risky than Bluejay Diagnostics. The stock trades about -0.47 of its potential returns per unit of risk. The Bluejay Diagnostics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 530.00 in Bluejay Diagnostics on August 27, 2024 and sell it today you would lose (155.00) from holding Bluejay Diagnostics or give up 29.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuroone Medical Technologies vs. Bluejay Diagnostics
Performance |
| Timeline |
| Neuroone Medical Tec |
| Bluejay Diagnostics |
Neuroone Medical and Bluejay Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuroone Medical and Bluejay Diagnostics
The main advantage of trading using opposite Neuroone Medical and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuroone Medical position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.| Neuroone Medical vs. BioSig Technologies, Common | Neuroone Medical vs. Biomerica | Neuroone Medical vs. Beyond Air | Neuroone Medical vs. Movano Inc |
| Bluejay Diagnostics vs. Bone Biologics Corp | Bluejay Diagnostics vs. Nuwellis | Bluejay Diagnostics vs. Heart Test Laboratories | Bluejay Diagnostics vs. Tivic Health Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |